Specialty Pharmacy

Phase 3 study results show high efficacy and improved renal and bone safety parameters with tenofovir alafenamide regimen.

Researchers achieve promising first step in new HIV treatment approach.

David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, discusses methods to improve communication among drug manufacturers and health care providers.

Research compares multidimensional approaches with uni-dimensional interventions.

Antibiotics suppress bacterial growth but may facilitate fungi growth.

Despite the advent of a multitude of non-insulin therapies, insulin maintains its place in diabetes management.

Sofosbuvir and velpastavir combination being evaluated for hepatitis C genotypes 1-6.

Targeted intervention programs could offer significant benefits in HCV prevention.

Palbociclib has been found effective inhibiting the mobilization of enzymes that contribute to the rapid division of tumor cells.

Major drug companies are starting to make cheap versions of blockbuster hepatitis C drugs available to people in poor and many middle-income nations.

Sprouty 2 gene works differently in colorectal cancer than in other types of cancers.

A middle-aged man experienced complete remission of type 2 diabetes after cure of chronic hepatitis C virus.

CVS Health, Walgreens, Walmart, Express Scripts, and Rite Aid pharmacies all appear in a list of the top 10 most frequent violators of HIPAA.

Sterile drug compounder Pharmedium is voluntarily recalling multiple lots of norepinephrine bitartrate added to 0.9% sodium chloride in light of complaints from hospitals of a slight discoloration in the mixture.

The public interest journalism group ProPublica examined records from 2011 through 2014 and found that not only are HIPAA violations common, but they also typically go unpunished.

Study finds health care access was of paramount importance to people with chronic conditions and their caregivers.

Hospital employment of physicians and ownership of physician practices is associated with higher prices and spending for outpatient care in the commercial health care market.

In 2014, Forbes said the Massachusetts Health Connector was the worst exchange in the nation.

St. Peter's University Hospital of New Brunswick argued that it will suffer irreparable harm if Horizon's OMNIA plan takes effect in the new year and it is not included in the preferred hospital tier.

Alpha therapy shows promise in selectively killing infected cells from the central nervous system.

Research may lead to new treatment approach for cancer.

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC discusses the use of technology to optimize clinical services in specialty pharmacy.

Interstitial lung disease may also precede the first symptoms of IBD.

Interventions needed to get MS patients more active.

Combination of treatments may slow disease progression.

Top stories from last week in oncology drug development.

Sending patients home with information from their files can reinforce pertinent information.

Most read HCV articles of the year.

Most read HIV articles from the past year.

Most read multiple sclerosis articles from the past year.